US Medicare HMO/PBM political funds slammed
<p class="source">Pharma Marketletter</p>
<p>"Under the current program, seniors and taxpayers will pay too much for prescription drugs by being forced to subsidize HMO and drug company profits," stated FTCR spokesman David Fink, who called on Congress to "untie the hands of the federal government and allow the Medicare program to use its market clout to negotiate cheaper drugs."</p>
